(Q82860831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543930%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543930%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1 reference

1 reference

Hepsen IF

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543930%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ozkaya E

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543930%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

17 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543930%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543930%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543930%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543930%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

453-458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16543930%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.eye.6702243

18 January 2020

exact match

0 references

cites work

Impact of intraocular pressure regulation on visual fields in open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Intraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021

24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702243

7 January 2021